European Pharmaceutical Review have partnered with Datamonitor Group to present a series of reports covering every aspect of the pharmaceutical industry.
The global pharmaceuticals market was worth $733bn in 2010. With the patents of many of the world’s best-selling drugs expiring, the market is currently in the middle of a “patent cliff”. This Case Study looks at the various routes companies are taking in order to minimize the adverse effects caused by this “patent cliff”.
OTC Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
MarketLine’s Industry Profiles will help you to form a clear picture of individual sectors, including who is operating within them and how they are performing.
Concise and accurate, Industry Profiles are presented within the globally recognized Porter’s Five Forces analysis framework to help you understand and apply key insights in minutes.
They are the ideal starting point for gaining a top-level understanding of the pharmaceutical and healthcare sectors – across the globe.
Each Industry Profile includes:
Remicade is a drug used in treating a variety of immune system diseases, and its active ingredient is produced through biotechnology. Johnson & Johnson reported Remicade sales of $4.6bn in 2010, and the drug is the best-selling “biologic” in the world. This case study examines its long journey from an academic research laboratory to a leading position in the pharmaceutical market.
MarketLine’s Country and Industry Analysis Profiles provide a quick and convenient access point to information on a wide breadth of industries and the countries in which they operate – presenting a holistic overview of individual sectors and their geographic context…
Our Country and Industry Analysis Profiles Include:
Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
European Pharmaceutical Review in association with Datamonitor Group is pleased to introduce you to our array of company profiles available on our RESEARCH STORE – your one stop to all research needs!
Browse and search for the latest merger and acquisition activity, lists of company products and services, and key competitor information for our entire portfolio of companies now…
Our Company Profiles:
This report focuses on the socio-demographic and economic trends that are shaping the healthcare industry, and their impact on healthcare payers and the pharmaceutical industry, both directly and indirectly.
United Kingdom: Pharmaceuticals Industry Guide is an essential resource for top-level data & analysis covering the United Kingdom Pharmaceuticals industry. It includes data on market size & segmentation, textual analysis of the key trends & competitive landscape. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals & Pharmaceuticals.
The treatment of cancer has seen a dramatic shift with the addition of molecular targeted therapies. The mixed and unpredictable responses to these targeted therapies are driving the pharmaceutical industry to search for disease and patient characteristics which confer the best response rates. Identification of biomarkers and companion diagnostics will pave the way for personalized cancer therapy.
This report covers the development of therapies to replace human cells or promote their regeneration: including cell therapies, tissue engineering, drugs, and medical devices. Each company profiled has at least one project in preclinical or Phase I study. Many also have later stage or launched products, which are covered briefly to illustrate the potential of the next generation of candidates.
This report investigates current trends and opportunities affecting decisions on whether or not to outsource drug discovery. Outsourcing to low cost offshore destinations such as China and India are examined in detail. The report also covers a variety of strategic collaborations, academic partnerships and outsourcing opportunities along with case studies.
This free to view Mass Spectrometry in-depth focus features articles from experts at University of British Columbia and University of Colorado Denver.
This free to view Stem Cells in-depth focus features articles from experts at Max Planck Institute for Molecular Genetics, Heinrich Heine University and Newcastle University.
ABB Analytical Measurements | Analytik Jena AG | Aptalis Pharmaceutical Technologies | ASM - Aerosl-Service AG | Azbil BioVigilant, Inc. | B&W Tek, Inc. | Bio-Optronics, Inc. | bioMérieux | BioTrends – Archilex SA | BMG LABTECH GmbH | Bruker Daltonik GmbH | CAMO Software AS | Catalent Pharma Solutions | Chemical Plant Equipment | Chemspec Europe Ltd | CI Precision | Dow Chemical Company Ltd | DSM Biologics | FOSS NIRSystems, Inc. | GE Analytical Instruments | GenScript USA Inc. | Gerresheimer Group | HACH LANGE GMBH | HAMAMATSU PHOTONICS EUROPE | I Holland Limited | IDBS | IONIMED Analytik GmbH | Lonza | MPI Research | Natoli Engineering Company, Inc. | PANalytical B.V. | Patheon Inc | ReAgent | Roche | Siemens AG | Sirius Analytical Instruments Ltd | TSI | Waters Corporation |
© Russell Publishing Limited, 2010-2013. All rights reserved | Website design and development by e-Motive Media | Terms & conditions of use | Privacy policy
Login to access exclusive content